Category: Proteins & Peptides

Active filters

Reference: C-64460

Recombinant Human soluble Vascular Endothelial Growth Factor Receptor 1 (flt-1, native, Sf9 insect cell-derived)

Reference: C-64465

Recombinant Human soluble Vascular Endothelial Growth Factor Receptor 1, Domain 1-7 (flt-1, Fc chimera; Sf9 insect cell-derived)

Reference: 11188-25

Peptide sequence: PGP • PGP is a tripeptide molecule and an established biomarker for COPD and CF. PGP functions as a neutrophil chemoattractant and is derived from the proteolytic cleavage of collagen in the extracellular matrix by a multistep cascade.

Reference: C-64469

Recombinant Human soluble Vascular Endothelial Growth Factor Receptor 2 (sKDR, native; insect cell-derived)

Reference: 11188-5

Peptide sequence: PGP • PGP is a tripeptide molecule and an established biomarker for COPD and CF. PGP functions as a neutrophil chemoattractant and is derived from the proteolytic cleavage of collagen in the extracellular matrix by a multistep cascade.

Reference: C-64470

Recombinant Human soluble Vascular Endothelial Growth Factor Receptor 2, Domain 1-7 (sKDR, CD309; Sf9 insect cell-derived)

Reference: 11189-25

Peptide sequence: N-terminal acetylated-PGP • N-acetyl-PGP is a tripeptide that functions as a neutrophil chemoattractant. N-acetyl-PGP and PGP induce the recruitment of neutrophils (PMN) through stimulation of chemokine CXC receptors.

Reference: C-64472

Recombinant Human soluble Vascular Endothelial Growth Factor Receptor 2, Domain 1-7 (sKDR, CD309, Fc chimera; Sf9 insect cell-derived)

Reference: 11189-5

Peptide sequence: N-terminal acetylated-PGP • N-acetyl-PGP is a tripeptide that functions as a neutrophil chemoattractant. N-acetyl-PGP and PGP induce the recruitment of neutrophils (PMN) through stimulation of chemokine CXC receptors.

Reference: 120112-200

Peptide Sequence: human amino acids 331-352 (ALEPGPSESLTASSPLKLNELN)(4425) · To be used in conjunction with Cayman’s BLT1 receptor polyclonal antibodies (Catalog Nos. 100019 and 120114) to block protein-antibody complex formation during analysis for the BLT1 receptor.